A phase II trial of Yeliva in patients with moderate to severe ulcerative colotis
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Opaganib (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 28 Feb 2017 New trial record
- 23 Feb 2017 According to a RedHill Biopharma media release, this trial is expected to initiate in the second half of 2017.